A 68-year-old man is evaluated in the intensive care unit for worsening respiratory distre… — USMLE Step 2 CK

A 68-year-old man is evaluated in the intensive care unit for worsening respiratory distress. He was admitted 48 hours ago for septic shock secondary to a urinary tract infection. During his initial resuscitation, he received 4 liters of intravenous isotonic crystalloids. Blood cultures drawn on admission grew *Escherichia coli* susceptible to ceftriaxone, ciprofloxacin, and trimethoprim-sulfamethoxazole. He is currently receiving empirical intravenous piperacillin-tazobactam. His medical history includes severe chronic obstructive pulmonary disease (COPD) and hypertension.

Vital signs are temperature 37.2°C (99.0°F), blood pressure 152/92 mm Hg, pulse 112/min, and respirations 32/min. Pulse oximetry shows 88% on a high-flow nasal cannula ( $FiO_2$ 60%). Physical examination reveals jugular venous distension to 9 cm $H_2O$ . Cardiac auscultation reveals a regular tachycardia with a prominent S3 gallop. Lung auscultation reveals bilateral basilar crackles. No significant wheezing is appreciated.

Arterial blood gas analysis on current settings shows:

Parameter	Value
pH	7.22
$P_aCO_2$	42 mm Hg
$P_aO_2$	60 mm Hg
$HCO_3^-$	17 mEq/L

Which of the following are the most appropriate next steps in management? (Select 2)

Initiate a trial of noninvasive positive-pressure ventilation and administer intravenous furosemideAnswer
Transition current antimicrobial therapy to intravenous ceftriaxoneAnswer
C
Administer systemic methylprednisolone and scheduled nebulized ipratropium-albuterol
D
Maintain current respiratory interventions as arterial blood gas analysis demonstrates appropriate respiratory compensation
E
Continue intravenous piperacillin-tazobactam to ensure adequate broad-spectrum coverage for a potential secondary hospital-acquired infection

Answer

The most appropriate next steps are to initiate noninvasive positive-pressure ventilation with intravenous furosemide, and to transition the antimicrobial therapy to intravenous ceftriaxone.

This patient requires simultaneous management of two distinct critical care issues. First, his respiratory distress is driven by acute decompensated heart failure (ADHF) following aggressive fluid resuscitation (4L of normal saline), evidenced by elevated JVP, an S3 gallop, and pulmonary crackles. Furthermore, his ABG reveals a primary metabolic acidosis (pH 7.22,

HCO_3^-

17 mEq/L) complicated by a superimposed acute respiratory acidosis. Using Winter's formula (

1.5 \times 17 + 8 \pm 2

), his expected

P_aCO_2

is 31.5 to 35.5 mm Hg. His actual

P_aCO_2

of 42 mm Hg indicates inadequate respiratory compensation, signaling severe respiratory muscle fatigue and impending failure. This requires immediate noninvasive positive-pressure ventilation (NPPV) and intravenous furosemide. Second, the patient is on unnecessarily broad-spectrum antibiotics (piperacillin-tazobactam) despite having culture results demonstrating an *Escherichia coli* isolate susceptible to narrower-spectrum agents. Good antimicrobial stewardship dictates immediate de-escalation to ceftriaxone.

Step-by-Step Solution

Analyze the clinical presentation to differentiate the cause of respiratory distress.

Recent 4L fluid resuscitation, JVD, S3 gallop, and crackles indicate cardiogenic pulmonary edema (ADHF), not a COPD exacerbation.

Accurate physical exam interpretation prevents incorrect administration of steroids and bronchodilators.

Evaluate the arterial blood gas for acid-base status and compensation.

Primary metabolic acidosis (

HCO_3^-

17) with expected

P_aCO_2

of 31.5-35.5. The actual

P_aCO_2

(42) is higher, revealing a superimposed respiratory acidosis.

Identifying the uncompensated/mixed acidosis confirms impending respiratory muscle fatigue requiring ventilatory support like NPPV.

Select interventions to manage the ADHF and impending respiratory failure.

NPPV and intravenous furosemide are indicated.

NPPV decreases work of breathing and improves oxygenation, while furosemide diureses the iatrogenic volume overload.

Apply principles of antimicrobial stewardship to the current regimen.

Transition from piperacillin-tazobactam to ceftriaxone.

Culture susceptibilities are known, and de-escalation prevents the emergence of resistant organisms.

Key Concept

In the intensive care setting, accurately diagnosing iatrogenic acute decompensated heart failure (ADHF) over a COPD exacerbation, recognizing concurrent respiratory failure via Winter's formula, and actively de-escalating antibiotics are critical simultaneous management priorities.

Question

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Topics

More questions from this topic